Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.32

+4.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JanyBlueEyes who wrote (4972)	3/21/1999 10:58:00 PM
From: Cacaito	of 5736

I now understand "bleaching" it is just the decrease in jaundice (yellow) color when bilirubin levels come down under phototherapy. It is not "ashy, white, gray " or any other weird color. Elmhurst study was by CCSI (not sprx): ncbi.nlm.nih.gov It was the data from the above study that CCSI presented to the FDA. Notice that Elmhurst is a Queens affiliate of the Mount Sinai Medical Center/New York City. Sprx has been in most if not all of those meetings. CCSI has a definite advantage at the moment: Colormate is approved for testing during phototherapy (turn the light off before testing). Price war could be a major factor. CCSI lack of partner is a huge factor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next